|
PDXDC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.420200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.164300E-02 |
| Normal-vs-Stage2 |
5.202000E-01 |
| Normal-vs-Stage3 |
1.421850E-02 |
| Normal-vs-Stage4 |
6.318000E-02 |
| Stage1-vs-Stage2 |
4.249600E-01 |
| Stage1-vs-Stage3 |
1.573820E-01 |
| Stage1-vs-Stage4 |
6.340800E-01 |
| Stage2-vs-Stage3 |
1.125650E-01 |
| Stage2-vs-Stage4 |
3.090800E-01 |
| Stage3-vs-Stage4 |
5.791800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.853700E-02 |
| Normal-vs-AfricanAmerican |
6.973200E-01 |
| Normal-vs-Asian |
2.613600E-02 |
| Caucasian-vs-AfricanAmerican |
3.884800E-01 |
| Caucasian-vs-Asian |
4.475800E-01 |
| AfricanAmerican-vs-Asian |
1.893160E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.692000E-02 |
| Normal-vs-Female |
6.315600E-02 |
| Male-vs-Female |
9.267800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.296400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.690100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.431230E-01 |
| Normal-vs-Age(81-100Yrs) |
2.124200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.907400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.615600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.527200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.949600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.707600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.684200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.359600E-01 |
| Classical-VS-Follicular |
3.957600E-01 |
| Classical-VS-Other |
4.878800E-01 |
| Classical-VS-Normal |
1.615780E-01 |
| Tall-VS-Follicular |
6.951600E-01 |
| Tall-VS-Other |
8.226800E-01 |
| Tall-VS-Normal |
5.068200E-02 |
| Follicular-VS-Other |
7.239800E-01 |
| Follicular-VS-Normal |
8.868200E-02 |
| Other-VS-Normal |
1.887050E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.553800E-02 |
| Normal-vs-N1 |
2.606200E-02 |
| N0-vs-N1 |
5.121800E-01 |
|
|
